0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Poliomyelitis Vaccine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-26P2110
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Poliomyelitis Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Poliomyelitis Vaccine Market Research Report 2024

Code: QYRE-Auto-26P2110
Report
January 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Poliomyelitis Vaccine Market

The Poliomyelitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliomyelitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliomyelitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Poliomyelitis Vaccine Market Report

Report Metric Details
Report Name Poliomyelitis Vaccine Market
Segment by Type
  • Poliomyelitis Vaccine Ⅰ
  • Poliomyelitis Vaccine Ⅱ
  • Poliomyelitis Vaccine Ⅲ
  • Oral Poliomyelitis Vaccine
Segment by Application
  • VAPP
  • VDPV
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Poliomyelitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Poliomyelitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Poliomyelitis Vaccine Market report?

Ans: The main players in the Poliomyelitis Vaccine Market are GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group, Eli Lilly

What are the Application segmentation covered in the Poliomyelitis Vaccine Market report?

Ans: The Applications covered in the Poliomyelitis Vaccine Market report are VAPP, VDPV

What are the Type segmentation covered in the Poliomyelitis Vaccine Market report?

Ans: The Types covered in the Poliomyelitis Vaccine Market report are Poliomyelitis Vaccine Ⅰ, Poliomyelitis Vaccine Ⅱ, Poliomyelitis Vaccine Ⅲ, Oral Poliomyelitis Vaccine

1 Poliomyelitis Vaccine Market Overview
1.1 Product Overview and Scope of Poliomyelitis Vaccine
1.2 Poliomyelitis Vaccine Segment by Type
1.2.1 Global Poliomyelitis Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Poliomyelitis Vaccine Ⅰ
1.2.3 Poliomyelitis Vaccine Ⅱ
1.2.4 Poliomyelitis Vaccine Ⅲ
1.2.5 Oral Poliomyelitis Vaccine
1.3 Poliomyelitis Vaccine Segment by Application
1.3.1 Global Poliomyelitis Vaccine Market Value by Application: (2024-2030)
1.3.2 VAPP
1.3.3 VDPV
1.4 Global Poliomyelitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliomyelitis Vaccine Revenue 2019-2030
1.4.2 Global Poliomyelitis Vaccine Sales 2019-2030
1.4.3 Global Poliomyelitis Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poliomyelitis Vaccine Market Competition by Manufacturers
2.1 Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poliomyelitis Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poliomyelitis Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Poliomyelitis Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliomyelitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliomyelitis Vaccine, Product Type & Application
2.7 Poliomyelitis Vaccine Market Competitive Situation and Trends
2.7.1 Poliomyelitis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poliomyelitis Vaccine Players Market Share by Revenue
2.7.3 Global Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliomyelitis Vaccine Retrospective Market Scenario by Region
3.1 Global Poliomyelitis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poliomyelitis Vaccine Global Poliomyelitis Vaccine Sales by Region: 2019-2030
3.2.1 Global Poliomyelitis Vaccine Sales by Region: 2019-2024
3.2.2 Global Poliomyelitis Vaccine Sales by Region: 2025-2030
3.3 Global Poliomyelitis Vaccine Global Poliomyelitis Vaccine Revenue by Region: 2019-2030
3.3.1 Global Poliomyelitis Vaccine Revenue by Region: 2019-2024
3.3.2 Global Poliomyelitis Vaccine Revenue by Region: 2025-2030
3.4 North America Poliomyelitis Vaccine Market Facts & Figures by Country
3.4.1 North America Poliomyelitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poliomyelitis Vaccine Sales by Country (2019-2030)
3.4.3 North America Poliomyelitis Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Poliomyelitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliomyelitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poliomyelitis Vaccine Sales by Country (2019-2030)
3.5.3 Europe Poliomyelitis Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliomyelitis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Poliomyelitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poliomyelitis Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Poliomyelitis Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Poliomyelitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliomyelitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poliomyelitis Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Poliomyelitis Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliomyelitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliomyelitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poliomyelitis Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poliomyelitis Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Poliomyelitis Vaccine Sales by Type (2019-2030)
4.1.1 Global Poliomyelitis Vaccine Sales by Type (2019-2024)
4.1.2 Global Poliomyelitis Vaccine Sales by Type (2025-2030)
4.1.3 Global Poliomyelitis Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Poliomyelitis Vaccine Revenue by Type (2019-2030)
4.2.1 Global Poliomyelitis Vaccine Revenue by Type (2019-2024)
4.2.2 Global Poliomyelitis Vaccine Revenue by Type (2025-2030)
4.2.3 Global Poliomyelitis Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Poliomyelitis Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poliomyelitis Vaccine Sales by Application (2019-2030)
5.1.1 Global Poliomyelitis Vaccine Sales by Application (2019-2024)
5.1.2 Global Poliomyelitis Vaccine Sales by Application (2025-2030)
5.1.3 Global Poliomyelitis Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Poliomyelitis Vaccine Revenue by Application (2019-2030)
5.2.1 Global Poliomyelitis Vaccine Revenue by Application (2019-2024)
5.2.2 Global Poliomyelitis Vaccine Revenue by Application (2025-2030)
5.2.3 Global Poliomyelitis Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Poliomyelitis Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Poliomyelitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Poliomyelitis Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Crucell
6.4.1 Crucell Corporation Information
6.4.2 Crucell Description and Business Overview
6.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Crucell Poliomyelitis Vaccine Product Portfolio
6.4.5 Crucell Recent Developments/Updates
6.5 China National Biotech Group
6.5.1 China National Biotech Group Corporation Information
6.5.2 China National Biotech Group Description and Business Overview
6.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 China National Biotech Group Poliomyelitis Vaccine Product Portfolio
6.5.5 China National Biotech Group Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eli Lilly Poliomyelitis Vaccine Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliomyelitis Vaccine Industry Chain Analysis
7.2 Poliomyelitis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliomyelitis Vaccine Production Mode & Process
7.4 Poliomyelitis Vaccine Sales and Marketing
7.4.1 Poliomyelitis Vaccine Sales Channels
7.4.2 Poliomyelitis Vaccine Distributors
7.5 Poliomyelitis Vaccine Customers
8 Poliomyelitis Vaccine Market Dynamics
8.1 Poliomyelitis Vaccine Industry Trends
8.2 Poliomyelitis Vaccine Market Drivers
8.3 Poliomyelitis Vaccine Market Challenges
8.4 Poliomyelitis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Poliomyelitis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Poliomyelitis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Poliomyelitis Vaccine Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Poliomyelitis Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Poliomyelitis Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Poliomyelitis Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Poliomyelitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Poliomyelitis Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Poliomyelitis Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Poliomyelitis Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Poliomyelitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Poliomyelitis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Poliomyelitis Vaccine Sales by Region (2019-2024) & (K Units)
    Table 18. Global Poliomyelitis Vaccine Sales Market Share by Region (2019-2024)
    Table 19. Global Poliomyelitis Vaccine Sales by Region (2025-2030) & (K Units)
    Table 20. Global Poliomyelitis Vaccine Sales Market Share by Region (2025-2030)
    Table 21. Global Poliomyelitis Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Poliomyelitis Vaccine Revenue Market Share by Region (2019-2024)
    Table 23. Global Poliomyelitis Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Poliomyelitis Vaccine Revenue Market Share by Region (2025-2030)
    Table 25. North America Poliomyelitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Poliomyelitis Vaccine Sales by Country (2019-2024) & (K Units)
    Table 27. North America Poliomyelitis Vaccine Sales by Country (2025-2030) & (K Units)
    Table 28. North America Poliomyelitis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Poliomyelitis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Poliomyelitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Poliomyelitis Vaccine Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Poliomyelitis Vaccine Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Poliomyelitis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Poliomyelitis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Poliomyelitis Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Poliomyelitis Vaccine Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Poliomyelitis Vaccine Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Poliomyelitis Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Poliomyelitis Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Poliomyelitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Poliomyelitis Vaccine Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Poliomyelitis Vaccine Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Poliomyelitis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Poliomyelitis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Poliomyelitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Poliomyelitis Vaccine Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Poliomyelitis Vaccine Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Poliomyelitis Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Poliomyelitis Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Poliomyelitis Vaccine Sales (K Units) by Type (2019-2024)
    Table 51. Global Poliomyelitis Vaccine Sales (K Units) by Type (2025-2030)
    Table 52. Global Poliomyelitis Vaccine Sales Market Share by Type (2019-2024)
    Table 53. Global Poliomyelitis Vaccine Sales Market Share by Type (2025-2030)
    Table 54. Global Poliomyelitis Vaccine Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Poliomyelitis Vaccine Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Poliomyelitis Vaccine Revenue Market Share by Type (2019-2024)
    Table 57. Global Poliomyelitis Vaccine Revenue Market Share by Type (2025-2030)
    Table 58. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Poliomyelitis Vaccine Sales (K Units) by Application (2019-2024)
    Table 61. Global Poliomyelitis Vaccine Sales (K Units) by Application (2025-2030)
    Table 62. Global Poliomyelitis Vaccine Sales Market Share by Application (2019-2024)
    Table 63. Global Poliomyelitis Vaccine Sales Market Share by Application (2025-2030)
    Table 64. Global Poliomyelitis Vaccine Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Poliomyelitis Vaccine Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Poliomyelitis Vaccine Revenue Market Share by Application (2019-2024)
    Table 67. Global Poliomyelitis Vaccine Revenue Market Share by Application (2025-2030)
    Table 68. Global Poliomyelitis Vaccine Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Poliomyelitis Vaccine Price (USD/Unit) by Application (2025-2030)
    Table 70. GSK Corporation Information
    Table 71. GSK Description and Business Overview
    Table 72. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. GSK Poliomyelitis Vaccine Product
    Table 74. GSK Recent Developments/Updates
    Table 75. Sanofi-Pasteur Corporation Information
    Table 76. Sanofi-Pasteur Description and Business Overview
    Table 77. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Sanofi-Pasteur Poliomyelitis Vaccine Product
    Table 79. Sanofi-Pasteur Recent Developments/Updates
    Table 80. Merck Corporation Information
    Table 81. Merck Description and Business Overview
    Table 82. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Merck Poliomyelitis Vaccine Product
    Table 84. Merck Recent Developments/Updates
    Table 85. Crucell Corporation Information
    Table 86. Crucell Description and Business Overview
    Table 87. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Crucell Poliomyelitis Vaccine Product
    Table 89. Crucell Recent Developments/Updates
    Table 90. China National Biotech Group Corporation Information
    Table 91. China National Biotech Group Description and Business Overview
    Table 92. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. China National Biotech Group Poliomyelitis Vaccine Product
    Table 94. China National Biotech Group Recent Developments/Updates
    Table 95. Eli Lilly Corporation Information
    Table 96. Eli Lilly Description and Business Overview
    Table 97. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Eli Lilly Poliomyelitis Vaccine Product
    Table 99. Eli Lilly Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Poliomyelitis Vaccine Distributors List
    Table 103. Poliomyelitis Vaccine Customers List
    Table 104. Poliomyelitis Vaccine Market Trends
    Table 105. Poliomyelitis Vaccine Market Drivers
    Table 106. Poliomyelitis Vaccine Market Challenges
    Table 107. Poliomyelitis Vaccine Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Poliomyelitis Vaccine
    Figure 2. Global Poliomyelitis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Poliomyelitis Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Poliomyelitis Vaccine Ⅰ Product Picture
    Figure 5. Poliomyelitis Vaccine Ⅱ Product Picture
    Figure 6. Poliomyelitis Vaccine Ⅲ Product Picture
    Figure 7. Oral Poliomyelitis Vaccine Product Picture
    Figure 8. Global Poliomyelitis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Poliomyelitis Vaccine Market Share by Application in 2023 & 2030
    Figure 10. VAPP
    Figure 11. VDPV
    Figure 12. Global Poliomyelitis Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Poliomyelitis Vaccine Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Poliomyelitis Vaccine Sales (2019-2030) & (K Units)
    Figure 15. Global Poliomyelitis Vaccine Average Price (USD/Unit) & (2019-2030)
    Figure 16. Poliomyelitis Vaccine Report Years Considered
    Figure 17. Poliomyelitis Vaccine Sales Share by Manufacturers in 2023
    Figure 18. Global Poliomyelitis Vaccine Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Poliomyelitis Vaccine Players: Market Share by Revenue in 2023
    Figure 20. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Poliomyelitis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Poliomyelitis Vaccine Sales Market Share by Country (2019-2030)
    Figure 23. North America Poliomyelitis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Poliomyelitis Vaccine Sales Market Share by Country (2019-2030)
    Figure 27. Europe Poliomyelitis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Poliomyelitis Vaccine Revenue Market Share by Region (2019-2030)
    Figure 35. China Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Poliomyelitis Vaccine Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Poliomyelitis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Poliomyelitis Vaccine Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Poliomyelitis Vaccine Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E Poliomyelitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Poliomyelitis Vaccine by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Poliomyelitis Vaccine by Type (2019-2030)
    Figure 57. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Poliomyelitis Vaccine by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Poliomyelitis Vaccine by Application (2019-2030)
    Figure 60. Global Poliomyelitis Vaccine Price (USD/Unit) by Application (2019-2030)
    Figure 61. Poliomyelitis Vaccine Value Chain
    Figure 62. Poliomyelitis Vaccine Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS